Iron Accumulation During Cellular Senescence in Human Fibroblasts In Vitro

Antioxidants and Redox Signaling

Volumn 5, Issue 5, 2003, Pages 507-516

  Killilea, David W ^a,b   Atamna, Hani ^a   Liao, Charles ^b   Ames, Bruce N ^a,b  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b University of California Berkeley   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; HYDROXYLAMINE; IRON; N TERT BUTYLHYDROXYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL COUNT; CELL CULTURE; CELL FUNCTION; CELL IMMORTALIZATION; CELL KINETICS; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FLAME PHOTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IRON STORAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; SENESCENCE;

EID: 0142152329     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603770310158     Document Type: Article

References (50)

1. Ali SH and DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin Cancer Biol 11: 15-23, 2001.
2. Ames BN, Shigenaga MK, and Hagen TM. Mitochondrial decay in aging. Biochim Biophys Acta 1271: 165-170, 1995.
3. Atamna H, Paler-Martinez A, and Ames BN. N-t-Butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem 275: 6741-6748, 2000.
4. Atamna H, Robinson C, Ingersoll R, Elliott H, and Ames BN. N-t-Butyl hydroxylamine is an antioxidant that reverses age-related changes in mitochondria in vivo and in vitro. FASEB J 15: 2196-2204, 2001.
5. Atamna H, Killilea DW, Killilea AN, and Ames BN. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci U S A 99: 14807-14812, 2002.
6. Atamna H, Walter PB, and Ames BN. The role of heme and iron-sulfur clusters in mitochondrial biogenesis, maintenance, and decay with age. Arch Biochem Biophys 397: 345-353, 2002.
7. Babcock M, de Silva D, Oaks R, Davis-Kaplan S, Jiralerspong S, Montermini L, Pandolfo M, and Kaplan J. Regulation of mitochondrial iron accumulation by Yfhlp, a putative homolog of frataxin. Science 276: 1709-1712, 1997.
8. Beckman KB and Ames BN. The free radical theory of aging matures. Physiol Rev 78: 547-581, 1998.
9. Britton RS, Leicester KL, and Bacon BR. Iron toxicity and chelation therapy. Int J Hematol 76: 219-228, 2002.
10. Cairo G and Pietrangelo A. Iron regulatory proteins in pathobiology. Biochem J352 Pt 2: 241-250, 2000.
11. 2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J Biol Chem 276:19738-19745, 2001.
12. Carnpisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 38: 5-11, 2003.
13. Chen H, Campisi J, and Padmanabhan R. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J Biol Chem 271: 13959-13967, 1996.
14. 2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem J 332 (Pt 1): 43-50, 1998.
15. Connor JR, Snyder BS, Beard JL, Fine RE, and Mufson EJ. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res 31: 327-335, 1992.
16. Cristofalo VJ and Pignolo RJ. Molecular markers of senescence in fibroblast-like cultures. Exp Gerontol 31: 111-123, 1996.
17. Cuajungco MP, Faget KY, Huang X, Tanzi RE, and Bush AI. Metal chelation as a potential therapy for Alzheimer's disease. Ann N Y Acad Sci 920: 292-304, 2000.
18. Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 20: 627-662, 2000.
19. Fernandez-Real JM, Lopez-Bermejo A, and Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 51:2348-2354, 2002.
20. 2-induced senescence-like phenotype in human diploid fibroblasts. Free Radic Biol Med 33: 1334-1346, 2002.
21. Fukuyama R, Nakayama A, Nakase T, Toba H, Mukainaka T, Sakaguchi H, Saiwaki T, Sakurai H, Wada M, and Fushiki S. A newly established neuronal rho-0 cell line highly susceptible to oxidative stress accumulates iron and other metals. Relevance to the origin of metal ion deposits in brains with neurodegenerative disorders. J Biol Chem 277: 41455-41462, 2002.
22. Grune T. Oxidative stress, aging and the proteasomal system. Biogerontology 1: 31-40, 2000.
23. Hagen TM, Yowe DL, Bartholomew JC, Wehr CM, Do KL, Park JY, and Ames BN. Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc Natl Acad Sci U S A 94:3064-3069, 1997.
24. Hallgren B and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41-51, 1958.
25. Halliwell B. Free radicals and metal ions in health and disease. Proc Nutr Soc 46: 13-26, 1987.
26. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, and Agid Y. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56: 446-451, 1991.
27. Itahana K, Dimri G, and Campisi J. Regulation of cellular senescence by p53. Eur J Biochem 268: 2784-2791, 2001.
28. Liu J, Killilea DW, and Ames BN. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci U S A 99: 1876-1881, 2002.
29. Liu S, Thweatt R, Lumpkin CK Jr, and Goldstein S. Suppression of calcium-dependent membrane currents in human fibroblasts by replicative senescence and forced expression of a gene sequence encoding a putative calcium-binding protein. Proc Natl Acad Sci U S A 91: 2186-2190, 1994.
30. Massie HR, Aiello VR, and Williams TR. Iron accumulation during development and ageing of Drosophila. Mech Ageing Dev 29: 215-220, 1985.
31. Massie HR, Aiello VR, and Williams TR. Inhibition of iron absorption prolongs the life span of Drosophila. Mech Ageing Dev 67: 227-237, 1993.
32. Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, and Li QX. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem 277:44670-44676, 2002.
33. Nunez-Millacura C, Tapia V, Munoz P, Maccioni RB, and Nunez MT. An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells. J Neurochem 82: 240-248, 2002.
34. Packer L and Smith JR. Extension of the lifespan of cultured normal human diploid cells by vitamin E: a reevaluation. Proc Natl Acad Sci U S A 74: 1640-1641, 1977.
35. Pantopoulos K and Hentze MW. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J 14:2917-2924, 1995.
36. Perez de Nanclares G, Castano L, Gaztambide S, Bilbao JR, Pi J, Gonzalez ML, and Vazquez JA. Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis. N Engl J Med 343: 890-891, 2000.
37. Perry G, Taddeo MA, Petersen RB, Castellani RJ, Harris PL, Siedlak SL, Cash AD, Liu Q, Nunomura A, Atwood CS, and Smith MA. Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals 16: 77-81, 2003.
38. Poot M. Oxidants and antioxidants in proliferative senescence. Mutat Res 256: 177-189, 1991.
39. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803-811, 1992.
40. Smith MA, Harris PL, Sayre LM, and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A 94: 9866-9868, 1997.
41. Sohal RS, Allen RG, Farmer KJ, and Newton RK. Iron induces oxidative stress and may alter the rate of aging in the housefly, Musca domestica. Mech Ageing Dev 32: 33-38, 1985.
42. Sugarman B and Munro HN. Altered accumulation of zinc by aging human fibroblasts in culture. Life Sci 26: 915-920, 1980.
43. Sullivan JL. Stored iron and ischemic heart disease. Empirical support for a new paradigm. Circulation 86: 1036-1037, 1992.
44. Taketani S, Adachi Y, and Nakahashi Y. Regulation of the expression of human ferrochelatase by intracellular iron levels. Eur J Biochem 267: 4685-4692, 2000.
45. Walter PB, Beckman KB, and Ames BN. The role of iron and mitochondria in aging. In: Understanding the Process of Aging, edited by Cadenas E and Packer L. New York: Marcel Dekker, Inc., 1999, pp. 203-227.
46. Walter PB, Knutson MD, Paler-Martinez A, Lee S, Xu Y, Viteri FE, and Ames BN. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci U S A 99: 2264-2269, 2002.
47. Wolf FI, Torsello A, Covacci V, Fasanella S, Montanari M, Boninsegna A, and Cittadini A. Oxidative DNA damage as a marker of aging in WI-38 human fibroblasts. Exp Gerontol 37: 647-656, 2002.
48. Yantiri F and Andersen JK. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine toxicity. IUBMB Life 48: 139-141, 1999.
49. Yip R and Dallman PR. Iron. In: Present Knowledge in Nutrition, edited by Ziegler EE and Filer LJ. Washington, DC: ILSI Press, 1996, pp. 277-292.
50. Youdim MB and Riederer P. The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J Neural Transm Suppl 40: 57-67, 1993.